Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer

Identification of response biomarkers is a key step towards the development of personalised care. Here, Jayson et al. identify plasma Tie2 as a biomarker for the response of the tumor vasculature to anti-angiogenics in patients with metastatic colorectal cancer, suggesting that monitoring Tie2 level...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gordon C. Jayson, Cong Zhou, Alison Backen, Laura Horsley, Kalena Marti-Marti, Danielle Shaw, Nerissa Mescallado, Andrew Clamp, Mark P. Saunders, Juan W. Valle, Saifee Mullamitha, Mike Braun, Jurjees Hasan, Delyth McEntee, Kathryn Simpson, Ross A. Little, Yvonne Watson, Susan Cheung, Caleb Roberts, Linda Ashcroft, Prakash Manoharan, Stefan J. Scherer, Olivia del Puerto, Alan Jackson, James P. B. O’Connor, Geoff J. M. Parker, Caroline Dive
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/51bffec067d642f8a6e2d9a8af7b2752
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:51bffec067d642f8a6e2d9a8af7b2752
record_format dspace
spelling oai:doaj.org-article:51bffec067d642f8a6e2d9a8af7b27522021-12-02T16:50:10ZPlasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer10.1038/s41467-018-07174-12041-1723https://doaj.org/article/51bffec067d642f8a6e2d9a8af7b27522018-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-07174-1https://doaj.org/toc/2041-1723Identification of response biomarkers is a key step towards the development of personalised care. Here, Jayson et al. identify plasma Tie2 as a biomarker for the response of the tumor vasculature to anti-angiogenics in patients with metastatic colorectal cancer, suggesting that monitoring Tie2 levels may help guide therapy in the clinics.Gordon C. JaysonCong ZhouAlison BackenLaura HorsleyKalena Marti-MartiDanielle ShawNerissa MescalladoAndrew ClampMark P. SaundersJuan W. ValleSaifee MullamithaMike BraunJurjees HasanDelyth McEnteeKathryn SimpsonRoss A. LittleYvonne WatsonSusan CheungCaleb RobertsLinda AshcroftPrakash ManoharanStefan J. SchererOlivia del PuertoAlan JacksonJames P. B. O’ConnorGeoff J. M. ParkerCaroline DiveNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-14 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Gordon C. Jayson
Cong Zhou
Alison Backen
Laura Horsley
Kalena Marti-Marti
Danielle Shaw
Nerissa Mescallado
Andrew Clamp
Mark P. Saunders
Juan W. Valle
Saifee Mullamitha
Mike Braun
Jurjees Hasan
Delyth McEntee
Kathryn Simpson
Ross A. Little
Yvonne Watson
Susan Cheung
Caleb Roberts
Linda Ashcroft
Prakash Manoharan
Stefan J. Scherer
Olivia del Puerto
Alan Jackson
James P. B. O’Connor
Geoff J. M. Parker
Caroline Dive
Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer
description Identification of response biomarkers is a key step towards the development of personalised care. Here, Jayson et al. identify plasma Tie2 as a biomarker for the response of the tumor vasculature to anti-angiogenics in patients with metastatic colorectal cancer, suggesting that monitoring Tie2 levels may help guide therapy in the clinics.
format article
author Gordon C. Jayson
Cong Zhou
Alison Backen
Laura Horsley
Kalena Marti-Marti
Danielle Shaw
Nerissa Mescallado
Andrew Clamp
Mark P. Saunders
Juan W. Valle
Saifee Mullamitha
Mike Braun
Jurjees Hasan
Delyth McEntee
Kathryn Simpson
Ross A. Little
Yvonne Watson
Susan Cheung
Caleb Roberts
Linda Ashcroft
Prakash Manoharan
Stefan J. Scherer
Olivia del Puerto
Alan Jackson
James P. B. O’Connor
Geoff J. M. Parker
Caroline Dive
author_facet Gordon C. Jayson
Cong Zhou
Alison Backen
Laura Horsley
Kalena Marti-Marti
Danielle Shaw
Nerissa Mescallado
Andrew Clamp
Mark P. Saunders
Juan W. Valle
Saifee Mullamitha
Mike Braun
Jurjees Hasan
Delyth McEntee
Kathryn Simpson
Ross A. Little
Yvonne Watson
Susan Cheung
Caleb Roberts
Linda Ashcroft
Prakash Manoharan
Stefan J. Scherer
Olivia del Puerto
Alan Jackson
James P. B. O’Connor
Geoff J. M. Parker
Caroline Dive
author_sort Gordon C. Jayson
title Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer
title_short Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer
title_full Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer
title_fullStr Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer
title_full_unstemmed Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer
title_sort plasma tie2 is a tumor vascular response biomarker for vegf inhibitors in metastatic colorectal cancer
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/51bffec067d642f8a6e2d9a8af7b2752
work_keys_str_mv AT gordoncjayson plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT congzhou plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT alisonbacken plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT laurahorsley plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT kalenamartimarti plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT danielleshaw plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT nerissamescallado plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT andrewclamp plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT markpsaunders plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT juanwvalle plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT saifeemullamitha plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT mikebraun plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT jurjeeshasan plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT delythmcentee plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT kathrynsimpson plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT rossalittle plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT yvonnewatson plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT susancheung plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT calebroberts plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT lindaashcroft plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT prakashmanoharan plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT stefanjscherer plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT oliviadelpuerto plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT alanjackson plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT jamespboconnor plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT geoffjmparker plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
AT carolinedive plasmatie2isatumorvascularresponsebiomarkerforvegfinhibitorsinmetastaticcolorectalcancer
_version_ 1718383097973571584